MannKind Corp. (MNKD)
5.85
-0.06
(-1.02%)
USD |
NASDAQ |
Feb 10, 13:58
MannKind Market Cap : 1.796B for Feb. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.417B |
| Keros Therapeutics, Inc. | 524.02M |
| BioMarin Pharmaceutical, Inc. | 11.54B |
| Ionis Pharmaceuticals, Inc. | 13.57B |
| Vertex Pharmaceuticals, Inc. | 118.54B |
Market Cap Related Metrics
| PE Ratio | 62.10 |
| PS Ratio | 5.754 |
| PEG Ratio | 1.816 |
| Price to Free Cash Flow | 42.24 |
| Price | 5.85 |
| Earnings Yield | 1.61% |
| PEGY Ratio | 1.816 |
| Operating PE Ratio | 23.66 |
| Normalized PE Ratio | 41.52 |